FLT4 and neoplasm: Importantly, disrupting the conversation of tumor cells and LECs by interferring RNA or neutralizing antibodies to VEGFC or VEGFR3, has been shown to reduce the rate of lymph node metastasis in vitro and in vivo [14, 15].